Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses

被引:0
|
作者
Zhu, Dan [1 ,2 ]
Du, Yanqin [1 ,2 ]
Zhao, Mengxiao [1 ,2 ]
Ablikim, Dilhumare [1 ,2 ]
Huang, Hongming [1 ,2 ]
Pan, Wen [1 ,2 ]
Zeng, Xiaoqing [1 ,2 ]
Xu, Chunli [1 ,2 ]
Lu, Mengji [3 ]
Sutter, Kathrin [3 ]
Dittmer, Ulf [3 ]
Zheng, Xin [1 ,2 ]
Yang, Dongliang [1 ,2 ]
Liu, Jia [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Inst Infect Dis & Immun, Tongji Med Coll, Wuhan 430022, Peoples R China
[3] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45147 Essen, Germany
基金
中国国家自然科学基金;
关键词
Hepatitis B virus; B cells; CD8+T cells; Hydrodynamic injection; CD4+T cells; Antigen presenting; CD19; CD20; B220; Liver; VIRUS CORE ANTIGEN; RITUXIMAB; REACTIVATION; EXPRESSION; DEPLETION; CD4(+); ACTIVATION; IMMUNITY;
D O I
10.1007/s12072-024-10753-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThe pivotal role of antibody-producing B cells in controlling hepatitis B virus (HBV) infection is well-established. However, the antiviral role of B cells extends beyond antibody production, which has been insufficiently studied for HBV infection.MethodsUsing an HBV hydrodynamic injection (HDI) mouse model with B cell depletion or functional blockade, we detected HBV infection markers and assessed T cell function through enzyme-linked immunosorbent assay, RT-PCR and flow cytometry.ResultsWe observed significantly delayed serum and intrahepatic HBV clearance in permanently B cell-deficient and transiently B cell-depleted mice as well as mice with a functional B cell blockade. Blocking B cell function prior to or soon after HBV HDI resulted in delayed HBV clearance indicating that B cells contribute to initiating anti-HBV immune responses after following HBV exposure. Additionally, we also found an early activation of B cells following HBV exposure, characterized by an upregulation of MHC-II, CXCR5, and PD-1. Critically, the proliferation and activation of both CD4 + and CD8 + T cells were impaired after B cell depletion prior to HBV challenge. Consistently, depleting B cells reduced the generation of Th1, Th2, and Th17 cells in the spleen and hindered HBV-specific CD8 + T cell responses in the liver. Along these lines, the HBV-exposed B cells were more efficient in inducing HBcAg-specific CD8 + T cell responses in vitro.ConclusionsCollectively, our data indicate that B cells, in addition to antibody production, are essential for the development of anti-HBV cellular responses and intrahepatic HBV clearance during the early stage of HBV antigen exposure.
引用
收藏
页码:93 / 105
页数:13
相关论文
共 50 条
  • [1] MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance
    Yang, Shangqing
    Wang, Lu
    Pan, Wen
    Bayer, Wibke
    Thoens, Christine
    Heim, Kathrin
    Dittmer, Ulf
    Timm, Joerg
    Wang, Qin
    Yu, Qing
    Luo, Jinzhuo
    Liu, Yanan
    Hofmann, Maike
    Thimme, Robert
    Zhang, Xiaoyong
    Chen, Hongtao
    Wang, Hua
    Feng, Xuemei
    Yang, Xuecheng
    Lu, Yinping
    Lu, Mengji
    Yang, Dongliang
    Liu, Jia
    JOURNAL OF HEPATOLOGY, 2019, 71 (04) : 685 - 698
  • [2] Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells
    Li, Li
    Barry, Vivian
    Daffis, Stephane
    Niu, Congrong
    Huntzicker, Erik
    French, Dorothy M.
    Mikaelian, Igor
    Lanford, Robert E.
    Delaney, William E.
    Fletcher, Simon P.
    JOURNAL OF HEPATOLOGY, 2018, 68 (05) : 912 - 921
  • [3] Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: A novel mechanism of HBV reactivation following anticancer chemotherapy
    Xu, Lei
    Tu, Zeng
    Xu, Ge
    Wang, Yuwei
    Pan, Wanlong
    Zhan, Xingxing
    Luo, Qiang
    Huang, Yuan
    Chen, Juan
    Huang, Ailong
    MOLECULAR MEDICINE REPORTS, 2014, 9 (04) : 1345 - 1350
  • [4] Interferon ? facilitates anti-HBV cellular immune response in a B cell-dependent manner
    Zhong, Shihong
    Li, Qiong
    Wen, Chunhua
    Li, Yifan
    Zhou, Yang
    Jin, Zihan
    Ye, Guofu
    Zhao, Yanda
    Hou, Jinlin
    Li, Yongyin
    Tang, Libo
    ANTIVIRAL RESEARCH, 2022, 207
  • [5] An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy
    Ma, Siyuan
    Chen, Xiaohua
    Tan, Quanhui
    Dai, Shenglan
    Li, Dan
    Wu, Shanshan
    Yu, Yongsheng
    Zang, Guoqing
    Tang, Zhenghao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (03) : 1041 - 1059
  • [6] Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
    Boni, Carolina
    Fisicaro, Paola
    Valdatta, Caterina
    Amadei, Barbara
    Di Vincenzo, Paola
    Giuberti, Tiziana
    Laccabue, Diletta
    Zerbini, Alessandro
    Cavalli, Albertina
    Missale, Gabriele
    Bertoletti, Antonio
    Ferrari, Carlo
    JOURNAL OF VIROLOGY, 2007, 81 (08) : 4215 - 4225
  • [7] HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses
    Sun, Bo
    da Costa, Kelly A. S.
    Alrubayyi, Aljawharah
    Kokici, Jonida
    Fisher-Pearson, Natasha
    Hussain, Noshin
    D'Anna, Stefano
    Piermatteo, Lorenzo
    Salpini, Romina
    Svicher, Valentina
    Kucykowicz, Stephanie
    Ghosh, Indrajit
    Burns, Fiona
    Kinloch, Sabine
    Simoes, Pedro
    Bhagani, Sanjay
    Kennedy, Patrick T. F.
    Maini, Mala K.
    Bashford-Rogers, Rachael
    Gill, Upkar S.
    Peppa, Dimitra
    HEPATOLOGY, 2024, 80 (03) : 649 - 663
  • [8] PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response
    Liu, LanLan
    Hou, Junwei
    Xu, Yuxiu
    Qin, Lijuan
    Liu, Weiwei
    Zhang, Han
    Li, Yang
    Chen, Mi
    Deng, Mengmeng
    Zhao, Bao
    Hu, Jun
    Zheng, Huaguo
    Li, Changfei
    Meng, Songdong
    PLOS ONE, 2020, 15 (07):
  • [9] How are HBV-specific CD8+ T-cell responses induced?
    Isogawa, Masanori
    Murata, Yasuhiro
    Kawashima, Keigo
    Tanaka, Yasuhito
    FUTURE VIROLOGY, 2018, 13 (12) : 825 - 827
  • [10] Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir
    Fu, Xiao-Zhong
    Ou, Yu
    Pei, Jian-Ying
    Liu, Ying
    Li, Jing
    Zhou, Wen
    Lan, Yan-Yu
    Wang, Ai-Min
    Wang, Yong-Lin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 49 : 211 - 218